(C) Daily Kos This story was originally published by Daily Kos and is unaltered. . . . . . . . . . . Standalone works cited, further reading (corollary) [1] ['This Content Is Not Subject To Review Daily Kos Staff Prior To Publication.', 'Backgroundurl Avatar_Large', 'Nickname', 'Joined', 'Created_At', 'Story Count', 'N_Stories', 'Comment Count', 'N_Comments', 'Popular Tags'] Date: 2023-01-31 The following are the cited works that sourced my most recent Covid diary, “Brains, Revisited.” The list is here for future reference. Covid & PrP – Works Cited & References for Further Reading Baazaoui, Narjes and Khalid Iqbal, “COVID-19 and Neurodegenerative Diseases: Prion-Like Spread and Long-Term Consequences.” Journal of Alzheimer’s Disease (2022), Vol. 88, No. 2. doi: 10.3233/JAD-220105 Baranova, Ancha et al., “Severe COVID-19 increases the risk of schizophrenia.” Psychiatry Research (2022), Vol. 317, Article 114809. doi: 10.1016/j.psychres.2022.114809 Beckman, Danielle et al., “SARS-CoV-2 infects neurons and induces neuroinflammation in a non-human primate model of COVID-19.” Cell Reports (2022), Vol. 41, Article 111573. doi: 10.1016/j.celrep.2022.111573 Bernardini, Andrea et al., “Creutzfeldt-Jakob disease after COVID-19: infection-induced prion protein misfolding? A case report.” PRION (2022), Vol. 16, No. 1. doi: 10.1080/19336896.2022.2095185 Bhinder, Khurram et al., “Bilateral basal ganglia ischemia associated with COVID-19: a case report and review of the literature.” Journal of Medical Case Reports (2021), Vol. 15, Article 563. doi: 10.1186/s13256-021-03165-x Charnley, Mirren et al., “Neurotoxic amyloidogenic peptides in the proteome of SARS-COV2: potential implications for neurological symptoms in COVID-19.” Nature Communications (2022), Vol. 13. doi: 10.1038/s41467-022-30932-1 Crunfli, Fernanda et al., “Morphological, cellular, and molecular basis of brain infection in COVID-19 patients.” PNAS (2022), Vol. 119, No. 35. doi: 10.1073/pnas.2200960119 Davis, Hannah, Eric Topol et al., “Long COVID: major findings, mechanisms and recommendations.” Nature Reviews Microbiology (2023). doi: 10.1038/s41579-022-00846-2 Esposito, Fabrizio et al., “Olfactory loss and brain connectivity after COVID-19.” Human Brain Mapping (2022), Vol. 43, No. 5. doi: 10.1002/hbm.25741 Fesharaki-Zadeh, Arman et al., “Clinical experience with the 𝛂2A-adrenoreceptor agonist, guanfacine, and N-acetylcysteine for the treatment of cognitive defects in Long COVID-19.” Neuroimmunology Reports (2023). doi: 10.1016/j.nerep.2022.100154 Hara, Hideyuki et al., “Neurotropic influenza A virus infection causes prion protein misfolding into infectious prions in neuroblastoma cells.” Nature Scientific Reports (2021), Vol. 11, Article 10109. doi: 10.1038/s41598-021-89586-6 Idrees, Danish and Vijay Kumar, “SARS-CoV-2 spike protein interactions with amyloidogenic proteins: Potential clues to neurodegeneration.” Biochemical and Biophysical Research Communications (2021), Vol. 554. doi: 10.1016/j.bbrc.2021.03.100 Lin, Lu et al., “Electroencephalographic Abnormalities are Common in COVID-19 and are Associated with Outcomes.” Annals of Neurology (2021), Vol. 89, No. 5. doi: 10.1002/ana.26060 Monbiot, George. “We are all playing Covid roulette. Without clean air, the next infection could permanently disable you.” The Guardian, January 26, 2023. http://www.guardian.com/commentisfree/jan/26/covid-roulette-clean-air-ventilation-long-covid Nuzzo, Domenico et al., “Long-Term Brain Disorders in Post Covid-19 Neurological Syndrome (PCNS) Patient.” Brain Sciences (2021), Vol. 11. doi: 10.3390/brainsci11040454 Reuber, Markus et al., “New variant Creutzfeldt-Jakob disease presenting with loss of taste and smell.” Journal of Neurology, Neurosurgery and Psychiatry (2001), Vol. 71, No. 3. doi: 10.1136/jnnp.71.3.412 Sanchez, Cristina et al., “Autoimmune Encephalitis After SARS-CoV-2 Infection.” Neurology (2021), Vol. 97. doi: 10.1212/WNL.0000000000012931 Schiff, Nicholas and Emery Brown. “Protective down-regulated states in the human brain: A possible lesson from COVID-19.” PNAS (2022), Vol. 119, No. 46. doi: 10.1073/pnas.2120221119 Serrano, Geidy et al., “Mapping of SARS-CoV-2 Brain Invasion and Histopathology in COVID-19 Disease.” medRxiv (2021). doi: 10.1101/2021.02.15.21251511 Shahzad, Shakeel and Mark Willcox, “The Possible Role of Prion-Like Viral Protein Domains on the Emergence of Novel Viruses as SARS-CoV-2.” Journal of Molecular Evolution (2022), Vol. 90, Nos. 3-4. doi: 10.1007/s00239-022-10054-4 Shen, Wei-Ben et al., “SARS-CoV-2 invades cognitive centers of the brain and induces Alzheimer’s-like neuropathology.” bioRxiv (2022), doi: 10.1101/2022.01.31.478476 Tavassoly, Omid et al., “Seeding Brain Protein Aggregation by SARS-CoV-2 as a Possible Long-Term Complication of COVID-19 Infection.” ACS Chemical Neuroscience (2020), Vol. 11, No. 22. doi: 10.1021/acschemneuro.0c00676 Vellieux, Geoffroy et al., “COVID-19 associated encephalopathy: Is there a specific EEG pattern?” Clinical Neurophysiology (2020), Vol. 131, No. 8. doi: 10.1016/j.clinph.2020.06.005 Zanusso, Gianluigi et al., “Detection of Pathologic Prion Protein in the Olfactory Epithelium in Sporadic Creutzfeldt–Jakob Disease.” New England Journal of Medicine (2003), Vol. 348, No. 8. doi: 10.1056/NEJMoa022043 Zanusso, Gianluigi et al., “Different Prion Conformers Target the Olfactory Pathway in Sporadic Creutzfeldt-Jakob Disease.” Annals of New York Academy of Sciences (2009), Vol. 1170. doi: 10.1111/j.1749-6632.2009.03905 Zhang, Jing, “Investigating neurological symptoms of infectious diseases like COVID-19 leading to a deeper understanding of neurodegenerative disorders such as Parkinson’s disease.” Frontiers in Neurology (2022), Vol. 13, Article 968193. doi: 10.3389/fneur.2022.968193 Zhao, Yuhai et al., “SARS-CoV-2, long COVID, prion disease and neurodegeneration.” Frontiers in Neuroscience (2022), Vol. 16. doi: 10.3389/fnins.2022.1002770 Deeper Reading Bilinksa, Katarzyna et al., “Expression of the ACE2 Virus Entry Protein in the Nervus Terminalis Reveals the Potential for an Alternate Route to Brain Infection in COVID-19.” Frontiers in Cellular Neuroscience (2021), Vol. 15, Article 674123. doi: 10.3389/fncel.2021.674123 Brooks, Linda. “MRI Reveals Significant Brain Abnormalities Post-COVID.” Neuroscience News, November 21, 2022. https://neurosciencenews.com/post-covid-brain-21904/ Casciato, Sara et al., “Factors underlying the development of chronic temporal lobe epilepsy in autoimmune encephalitis.” Journal of the Neurological Sciences (2019), Vol. 396. doi: 10.1016/j.jus.2018.10.026 da Silva, Gilnei et al., “High levels of extracellular ATP lead to different inflammatory responses in COVID-19 patients according to the severity.” Journal of Molecular Medicine (2022), Vol. 100, No. 4. doi: 10.1007/s00109-022-02185-4 da Silva-Júnior, Francisco et al., “Serial and prolonged EEG monitoring in anti-N-Methyl-D-Aspartate receptor encephalitis.” Clinical Neurophysiology (2014), Vol. 125, No. 8. doi: 10.1016/j.clinph.2014.01.001 De Luca, Pietro et al., “Entorhinal Cortex and Persistent Olfactory Loss in COVID-19 Patients: A Neuroanatomical Hypothesis.” Brain Sciences (2022), Vol. 12. doi: 10.3390/brainsci12070850 Douaud, Gwenaëlle et al., “SARS-CoV-2 is associated with changes in brain structure in UK Biobank.” Nature (2022), Vol. 604. doi: 10.1038/s41586-022-04569-5 Duan, Kuaikuai et al., “Alterations of frontal-temporal gray matter volume associate with clinical measures of older adults with COVID-19.” Neurobiology of Stress (2021), Vol. 14, Article 100326. doi: 10.1016/jynsh.2021.100126 Etter, Manina et al., “Severe Neuro-COVID is associated with peripheral immune signatures, autoimmunity and neurodegeneration: a prospective cross-sectional study.” Nature Communications (2022), Vol. 13. doi: 10.1038/s41467-022-34068-0 Fernández-Castañeda, Anthony et al, “Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation.” Cell, Vol. 185. doi: 10.1016/j.cell.2022.06.008 Green, Ryan et al., “SARS-CoV-2 infection increases the gene expression profile for Alzheimer’s disease risk.” Molecular Therapy: Methods & Clinical Development (2022), Vol. 27. doi: 10.1016/jomtm.2022.09.007 Hafiz, Rakibul et al., “Higher limbic and basal ganglia volumes in surviving COVID-negative patients and the relations to fatigue.” Neuroimage: Reports 2 (2022), Vol. 2, No. 2 (Article 100095). doi: 10.1016/j.ynirp.2022.100095 Huang, Yan et al., “Brain Imaging Changes in Patients Recovered from COVID-19: A Narrative Review.” Frontiers in Neuroscience (2022), Vol. 16, Article 855868. doi: 10.3389/fnins.2022.855868 Kulaga, Stephanie and Christopher Miller, “Viral respiratory infections and psychosis: A review of the literature and the implications of COVID-19.” Neuroscience and Biobehavioral Reviews (2021), Vol. 127. doi: 10.1016/j.neubiorev.2021.05.008 Lu, Yiping et al., “Cerebral Micro-Structural Changes in COVID-19 Patients – An MRI-based 3-month Follow-up Study.” EClinicalMedicine (2020), Vol. 25, Article 100484. doi: 10.1016/j.eclinm.2020.100484 Mavrikaki, Maria et al., “Severe COVID-19 is associated with molecular signatures of aging in the human brain.” Nature Aging (2022), Vol. 2. doi: 10.1038/s43587-022-00321-w Mizoguchi, Tomotaka et al., “Novel gEEG Biomarker to Distinguish Anti-NMDAR Encephalitis From Other Types of Autoimmune Encephalitis.” Frontiers in Immunology (2022), Vol. 13, Article 845272. doi: 10.3389/fimmu.2022.845272 Niesen, Maxime et al., “Structural and metabolic brain abnormalities in COVID-19 patients with sudden loss of smell.” European Journal of Nuclear Medicine and Molecular Imaging (2021), Vol. 48. doi: 10.1007/s00259-020-05154-6 Okayasu, Hiroaki et al., “Bickerstaff’s Brainstem Encephalitis Suspected as Functional Neurologic Disorders.” International Medical Case Reports Journal (2020), Vol. 13. doi: 10.2147/IMCRJ.S249818 Olivo, Sasha et al., “Rapidly evolving Creutzfeldt-Jakob disease in COVID-19: from early status epilepticus to fatal outcome.” Acta Neurologica Belgica (2022). doi: 10.1007/s13760-022-02023-x Ong, Wei-Yi et al., “ACE2, Circumventricular Organs and the Hypothalamus, and COVID-19.” NeuroMolecular Medicine (2022), Vol. 24, No. 4. doi: 10.1007/s12017-022-08706-1 Stefanou, Maria-Ioanna et al., “Neurological Manifestations of long-COVID syndrome: a narrative review.” Therapeutic Advances in Chronic Disease (2022), Vol. 13. doi: 10.1177/20406223221076890 Smith, Colin et al., “COVID-19-associated psychosis: A systematic review of case reports.” General Hospital Psychiatry (2021), Vol. 73. doi: 10.1016/j.genhosppsych.2021.10.003 Stix, Gary. “How COVID Might Sow Chaos in the Brain.” Scientific American, November 21, 2021. https://www.scientificamerican.com/article/how-covid-might-sow-chaos-in-the-brain/ Vasile, Claudiu et al., “Post COVID-19 Infection Psychosis: Could SARS-CoV-2 Virus Infection Be a Neuropsychiatric Condition That Triggers Psychotic Disorders? – A Case-Based Short Review.” Infection and Drug Resistance (2022), Vol. 15. doi: 10.2147/IDR.S373578 Versace, Viviana et al., “Intracortical GABAergic dysfunction in patients with fatigue and dysexecutive syndrome after COVID-19.” Clinical Neurophysiology (2021), Vol. 132, No. 5. doi: 10.1016/j.clinph.2021.03.001 Wheeler, Anne and Aristotle Voineskos, “A review of structural neuroimaging in schizophrenia: from connectivity to connectomics.” Frontiers in Human Neuroscience (2014), Vol. 8, Article 653. doi: 10.3389/fnhum.2014.00653 Wild, Conor et al., “Disentangling the cognitive, physical, and mental health sequelae of COVID-19.” Cell Reports Medicine (2022), Vol. 3. doi: 10.1016/j.xcrm.2022.100750 Yesilkaya, Umit et al., “COVID-19-related cognitive dysfunction may be associated with transient disruption in the DLPFC glutamatergic pathway.” Journal of Clinical Neuroscience (2021), Vol. 87. doi: 10.1016/j.jocn.2021.03.007 Zhou, Lingyan et al., “SARS-CoV-2: underestimated damage to nervous system.” Travel Medicine and Infectious Disease (2020). doi: 10.1016/j.tmaid.2020.10164 [END] --- [1] Url: https://www.dailykos.com/stories/2023/1/31/2150028/-Standalone-works-cited-further-reading-corollary Published and (C) by Daily Kos Content appears here under this condition or license: Site content may be used for any purpose without permission unless otherwise specified. via Magical.Fish Gopher News Feeds: gopher://magical.fish/1/feeds/news/dailykos/